What does this research mean for the field?

A risk-factor-based approach to thromboprophylaxis, prioritizing oral anticoagulation over antiplatelet therapy, is the recommended strategy for preventing thromboembolism in patients with atrial fibrillation according to updated ESC guidelines. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

To summarize European Society of Cardiology guidelines and clinical strategies for individual risk assessment and thromboembolism prevention in patients with atrial fibrillation.

January 1, 2011European Cardiology ReviewOpen Access

Prevention of Thromboembolism in Atrial Fibrillation Patients

View Full Paper

Ask AI

Bookmark

Why the study?

Does oral anticoagulation prevent thromboembolism in patients with atrial fibrillation?

Key Points

To summarize European Society of Cardiology guidelines and clinical strategies for individual risk assessment and thromboembolism prevention in patients with atrial fibrillation.
Reviewed updated European Society of Cardiology guidelines on the clinical management and stroke prophylaxis of atrial fibrillation.
Evaluated individual risk stratification approaches for thromboembolism and bleeding, including the therapeutic roles of antiplatelet agents and novel oral anticoagulants.
Oral anticoagulation demonstrates clear superiority over antiplatelet therapy for stroke prevention, yielding the greatest clinical benefit in individuals with the highest absolute risk of thromboembolism.
European Society of Cardiology guidelines provide risk-factor-based assessment tools to overcome the persistent underutilization of oral anticoagulation, particularly among elderly populations.

Structured PICO

Does oral anticoagulation prevent thromboembolism in patients with atrial fibrillation?

Population

Patients with atrial fibrillation

Intervention

Oral anticoagulation based on a risk-factor-based approach

Comparator

Antiplatelet therapy

Outcome

Prevention of thromboembolism and stroke

This review summarizes the updated ESC guidelines for stroke prevention in atrial fibrillation, emphasizing a risk-factor-based approach to oral anticoagulation.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May guide AF thromboprophylaxis decisions; leaves open prospective studies on guideline implementation.

Cite This Study

Kuzniatsova et al. (2011) studied this question.

synapsesocial.com/papers/6a1bd4c4d54006be995f1309 https://doi.org/10.15420/ecr.2011.7.1.37

Topics

Atrial fibrillation Anticoagulation in AF Persistent AF management

View Full Paper

Ask AI

Bookmark

Prevention of Thromboembolism in Atrial Fibrillation Patients

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Prevention of Thromboembolism in Atrial Fibrillation Patients

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider